Just - Evotec Biologics
Ronald Yeh is a Senior Scientist at Just - Evotec Biologics, where Ronald introduced the adeno-associated virus (AAV) platform and established the AAV Production facility with a $100K budget. Prior to this, Ronald worked at companies like Novo Nordisk and Genentech, where Ronald contributed to biotherapeutics discovery and development. Ronald has a B.S. in Chemistry from the University of California, Berkeley and has experience in teaching and mentoring from their time as a Study Group Leader and Tutor at the university.
This person is not in the org chart
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com